Research Article
Cardio-Ankle Vascular Index and Indices of Diabetic Polyneuropathy in Patients with Type 2 Diabetes
Table 1
Clinical profile of the patients (
).
| | Age (years) | 59.1 ± 11.2 | | Male (%) | 64.5 | | Body mass index (kg/m2) | 26.6 ± 5.0 | | Obesity (%) | 56.6 | | Systolic blood pressure (mmHg) | 136.0 ± 17.3 | | Diastolic blood pressure (mmHg) | 81.3 ± 14.2 | | Mean arterial pressure (mmHg) | 99.5 ± 13.7 | | Hypertension (%) (above140/90 mmHg or medication) | 48.2 | | Smoking (%) | 59.0 | | (Ex-smoker/current smoker) | 37.9/21.1 | | Alcohol (%) (excluding chance drinker) | 35.5 | | Duration of diabetes (years) | 13.0 ± 8.2 | | Retinopathy (%) | 47.2 (NDR, 52.8; SDR, 22.7; PPDR, 9.2; PDR, 15.3) | | Nephropathy (%) | 40.4 (stage 1, 59.6; stage 2, 27.1; stage 3, 10.8; stage 4, 2.4) | | Cystatin C (mmol/L) | 0.72 ± 0.25 | | Fasting plasma glucose (mmol/L) | 8.1 ± 2.5 | | HbA1c (mmol/mol) | 67.1 ± 1.3 | | TG (mmol/L) | 1.4 ± 0.8 | | HDL-C (mmol/L) | 1.4 ± 0.4 | | LDL-C (mmol/L)(Friedewald) | 2.5 ± 0.8 | | Dyslipidaemia (%) (TG > 3.9, HDL < 1.0, LDL > 3.6, or medication) | 73.5 |
|
|
Values are mean ± standard deviation.
BMI: body mass index; NDR: no diabetic retinopathy; PDR: proliferative diabetic retinopathy; PPDR: preproliferative diabetic retinopathy; SD: standard deviation; SDR: simple diabetic retinopathy; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol.
|
